2024-21680. Progynon Associates, et al.; Withdrawal of Approval of Four New Drug Applications  

  • Table 1—Approved NDAs for Which Required Reports Have Not Been Submitted

    Application No. Drug Holder
    NDA 004652 ORETON (testosterone) Pellets for Subcutaneous Implantations, 75 milligrams (mg) Progynon Associates, 9300 Wilshire Blvd., Beverly Hills, CA 90212.
    NDA 013268 WINSTEROID (stanozolol) Tablets, 2 mg Sterling Winthrop Inc., 90 Park Ave., New York, NY 10016.
    NDA 017455 Copper T Model TCu 200B (copper) Intrauterine Device Duramed Research, Inc., 425 Privet Rd., Horsham, PA 19044.
    NDA 205003 PRESTALIA (amlodipine besylate/perindopril arginine) Tablets, equivalent to (EQ) 2.5 mg base/3.5mg, EQ 5 mg base/7 mg, and EQ 10 mg base/14 mg Adhera Therapeutics, Inc., 224 Holding Ave., Wake Forest, NC 27588.

Document Information

Published:
09/23/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2024-21680
Dates:
Approval is withdrawn as of September 23, 2024.
Pages:
77515-77515 (1 pages)
Docket Numbers:
Docket No. FDA-2024-N-2219
PDF File:
2024-21680.pdf